Duterte to wait for FDA approval before using Sinopharm vax – Palace

MANILA, Philippines – President Rodrigo Duterte will wait for China-state-owned Sinopharm’s COVID-19 vaccine to secure an emergency use authorization (EUA) from the country’s Food and Drug Administration (FDA) before receiving a dose, his spokesperson said Tuesday.
Presidential Spokesperson Harry Roque made the announcement after the FDA confirmed that it has received Sinopharm’s application for an EUA that was filed on Monday afternoon.
“Mag-aantay po si president ng EUA dahil nabalita ko nga kahapon, mayroon na pong nag-apply ng EUA for the Sinopharm,” Roque said in a press briefing.
Securing an EUA from the FDA is part of the process for a vaccine to be legally used in the country.
The FDA earlier approved a compassionate use license for 10,000 doses of Sinopharm vaccines for the members of the Presidential Security Group.
The agency, however, clarified that the issuance of such a permit is not tantamount to a stamp of approval.
Duterte earlier expressed a preference for Sinopharm developed COVID-19 vaccines. – RRD (with details from Correspondent Rosalie Coz)